Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188083 · ClinicalTrials.gov registry record · NA
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT01188083 is a NA study that has completed, run by Emory University. The registered enrollment target is 53 participants.
The verdict
NCT01188083, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
Primary Objectives: 1. To determine whether a 4 week reduction in dietary fructose intake improves hepatic steatosis in overweight children who have a baseline high fructose consumption and hepatic steatosis. 2. To determine if a 4 week reduction of dietary fructose improves fasting plasma triglycerides, free fatty acids, very low-density lipoprotein, insulin and glucose as well as post-prandial levels in response to a high fructose meal. 3. To determine if a 4 week reduction of dietary fructose improves markers of oxidative stress. Study Design: A blinded randomized study comparing glucose beverages to isocaloric fructose beverages administered over 4 weeks.
Interventions
- DIETARY_SUPPLEMENT Fructose Drink
- DIETARY_SUPPLEMENT Glucose Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01188083
The ClinicalTrials.gov registry entry for NCT01188083 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fructose Drink is the first listed.
NCT01188083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01188083 about?
NCT01188083 is a clinical study titled "Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis". Primary Objectives: 1. To determine whether a 4 week reduction in dietary fructose intake improves hepatic steatosis in overweight children who have a baseline high fructose consumption and hepatic steatosis. 2. To determine if a 4 week reduction of dietary fructose improves fasting plasma triglyce...
What is the current status of trial NCT01188083?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2009-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01188083?
The interventions under investigation include: Fructose Drink (DIETARY_SUPPLEMENT), Glucose Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01188083?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.